Polyethylene glycol 3350 420000 mg / potassium chloride 1480 mg / sodium bicarbonate 5720 mg / sodium chloride 11200 mg [GaviLyte-N]
RxNorm 1719699

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1719699 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: polyethylene glycol 3350 420000 mg / potassium chloride 1480 mg / sodium bicarbonate 5720 mg / sodium chloride 11200 mg [GaviLyte-N].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDC
Polyethylene glycol 3350 420000 mg / potassium chloride 1480 mg / sodium bicarbonate 5720 mg / sodium chloride 11200 mg [GaviLyte-N]
AUI:12303687
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDCPrescribable

Semantic Branded Drug Component (SBDC):
Polyethylene glycol 3350 420000 mg / potassium chloride 1480 mg / sodium bicarbonate 5720 mg / sodium chloride 11200 mg [GaviLyte-N]
(Atom ID: 12303687)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG [GaviLyte-N]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1719699
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12303687
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDC
Semantic Branded Drug Component (Ingredient + Strength + Brand Name)
Source Code
1719699
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Polyethylene glycol-electrolyte solution (PEG-ES)


Polyethylene glycol-electrolyte solution (PEG-ES) is used to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) or barium enema (a test in which the colon is filled with a fluid and then x-rays are taken) so that the doctor will have a clear view of the walls of the colon. PEG-ES is in a class of medications called osmotic laxatives. It works by causing watery diarrhea so that the stool can be emptied from the colon. The medication also contains electrolytes to prevent dehydration and other serious side effects that may be caused by fluid loss as the colon is emptied.
[Learn More]


* Please review the disclaimer below.